or Try an Advanced Search...

    Technical Analysis for JSPR - Jasper Therapeutics, Inc

    Grade Last Price % Change Price Change
    C 20.98 1.40% 0.29
    JSPR closed up 1.4 percent on Wednesday, November 20, 2024, on 79 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical JSPR trend table...
    Date Alert Name Type % Chg
    50 DMA Support Bullish 0.00%
    NR7 Range Contraction 0.00%
    Multiple of Ten Bullish Other 0.00%
    Inside Day Range Contraction 0.00%
    Bullish Engulfing Bullish 1.40%
    Crossed Above 50 DMA Bullish 1.40%
    Stochastic Reached Oversold Weakness 1.40%
    Multiple of Ten Bullish Other 1.40%
    Oversold Stochastic Weakness 1.40%
    Fell Below 50 DMA Bearish 4.80%
    Older End-of-Day Signals for JSPR ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Support about 22 hours ago
    Down 3% about 22 hours ago
    Down 2 % about 22 hours ago
    Down 1% about 22 hours ago
    Up 1% about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    JSPR Chart by TradingView
    Basic chart:

    Profile

    Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company develops JSP191, a humanized monoclonal antibody for clearing hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Stem Cell Gene Therapy Transplantation Bone Marrow Hematopoietic Stem Cell

    Is JSPR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 16 We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate
    Nov 13 Jasper Therapeutics to Participate at Upcoming Investor Conferences
    Nov 8 Analysts Bullish on Jasper Therapeutics as Briquilimab Trials Show Promise
    Nov 7 Jasper Therapeutics GAAP EPS of -$1.24 misses by $0.17
    Nov 7 Jasper Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
    Oct 14 Jasper gains 11% on data for briquilimab in urticaria
    Oct 14 Jasper Therapeutics Reports Positive Data from SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
    Sep 10 Jasper Therapeutics Announces Health Canada Clearance of Clinical Trial Application for Phase 1b/2a Study of Briquilimab in Asthma
    Sep 4 Jasper Therapeutics to Present at Present at Upcoming September Investor Conferences
    Aug 13 Jasper Therapeutics GAAP EPS of -$0.97
    See more JSPR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 31.01
    52 Week Low 4.0
    Average Volume 267,278
    200-Day Moving Average 21.77
    50-Day Moving Average 20.28
    20-Day Moving Average 21.95
    10-Day Moving Average 22.28
    Average True Range 1.70
    RSI (14) 48.98
    ADX 25.0
    +DI 20.33
    -DI 21.41
    Chandelier Exit (Long, 3 ATRs) 20.18
    Chandelier Exit (Short, 3 ATRs) 23.88
    Upper Bollinger Bands 24.86
    Lower Bollinger Band 19.04
    Percent B (%b) 0.33
    BandWidth 26.54
    MACD Line 0.39
    MACD Signal Line 0.78
    MACD Histogram -0.3841
    Fundamentals Value
    Market Cap 315.91 Million
    Num Shares 15.1 Million
    EPS -8.30
    Price-to-Earnings (P/E) Ratio -2.53
    Price-to-Sales 0.00
    Price-to-Book 2.78
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 22.80
    Resistance 3 (R3) 22.60 21.80 22.49
    Resistance 2 (R2) 21.80 21.34 21.90 22.39
    Resistance 1 (R1) 21.39 21.05 21.60 21.59 22.29
    Pivot Point 20.59 20.59 20.69 20.69 20.59
    Support 1 (S1) 20.18 20.13 20.39 20.38 19.67
    Support 2 (S2) 19.38 19.84 19.48 19.57
    Support 3 (S3) 18.97 19.38 19.47
    Support 4 (S4) 19.17